ADMA Biologics, Inc. (ADMA) has a market capitalization of $2.5B and trades at $10.49. The 52-week range is 7.21-25.67.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 16.9, Earnings Per Share (EPS) of $0.62, annual revenue of $510.17M.
The stock has a beta of 0.82, operates in the Healthcare sector.
